Medical Bulletin 15/December/2022 Isra Zaman15 Dec 2022 1:45 PM ISTHere are the top medical news for the day:Type 2 diabetes may be reversed by Intermittent fasting Intermittent fasting diets have become popular in...
Ebola vaccines safety and immunogenicity trial shows potential Isra Zaman15 Dec 2022 9:15 AM ISTIn a context where many sub-Saharan African countries regularly face Ebola outbreaks, vaccines are seen as a central tool to fight the spread of the...
Medical Bulletin 12/December/2022 Isra Zaman12 Dec 2022 2:15 PM ISTHere are the top medical news for the day:Lasting improvements in urinary incontinence by weight-loss surgeryUrinary incontinence is a common...
73 percent of patients in two clinical trials exhibit success in experimental cancer therapy Isra Zaman12 Dec 2022 9:45 AM ISTNearly all patients with myeloma who receive standard therapies continually relapse. Patients who relapse or become resistant to all approved...
TAILORx trial's 12 years of recurrence and survival outcomes in more than 10,000 women with early breast cancer Isra Zaman7 Dec 2022 9:45 AM ISTEstrogen receptor-positive (ER+) and HER2-negative (HER2-) breast cancer with no spread to the lymph nodes accounts for about one-half of all new...
ICMR approves extension of Clinical Trials Registry by three months Revu suresh19 Aug 2022 9:30 AM ISTNew Delhi: The apex research regulator, the Indian Council of Medical Research (ICMR) has granted a three-month extension to the Clinical Trials...
Covid out Clinical Trial Isra Zaman19 Aug 2022 9:15 AM ISTPublished in the New England Journal of Medicine, researchers-led by the University of Minnesota Medical School and School of Public Health- have...
Gut microbes differ in men with prostate cancer and those with benign hypertrophy Dr. Kamal Kant Kohli5 July 2022 6:00 AM ISTResearchers have found a significant difference in the gut microbiota of men with prostate cancer, compared with those who have benign biopsies. The...
Intravascular lithotripsy effective option for severely calcified peripheral lesions: Disrupt PAD III trial Dr. Kamal Kant Kohli20 May 2022 10:00 AM ISTATLANTA, GA: One year outcomes from the Disrupt PAD III Trial comparing intravascular lithotripsy (IVL) with a drug-coated balloon (DCB) to...
Evidence mounts for need to study Pfizer oral antiviral treatment Paxlovid for long COVID: Researchers Ruchika Sharma8 May 2022 10:30 AM ISTPfizer spokesman Kit Longley said company does not have any current long COVID studies underway, but was monitoring data from ongoing clinical studies...
Sinovac, Sinopharm Omicron-specific vaccine candidates approved for clinical trial in Hong Kong Ruchika Sharma18 April 2022 11:55 AM ISTThe Sinopharm candidates will be tested as boosters in adults who have already received two or three vaccine doses, CNBG said.
COVID-19 vaccine not associated with major fetal structural anomalies detectable on ultrasound: JAMA Dr. Kamal Kant Kohli6 April 2022 9:15 AM ISTmajor fetal structural anomalies identified
